Mannkind to Host Product Theater and Booth at the American Diabetes Association's 82nd Scientific Sessions in New Orleans, June 3-7
globenewswire.com
news
2022-06-03 00:00:00

WESTLAKE VILLAGE, Calif., June 03, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative therapeutic products for patients with endocrine and orphan lung diseases, will showcase its mealtime insulin solutions and expanding efforts within the diabetes community at the American Diabetes Association's 82nd Scientific Sessions, June 3-7 in New Orleans. 'MannKind is committed to providing products that address unmet needs for patients living with diabetes,' said Alejandro Galindo, Executive Vice President, Endocrine Business Unit for MannKind Corporation.
